Header Logo

Connection

Oluwatomisin Atolagbe to Receptors, Immunologic

Back to Details
This is a "connection" page, showing publications Oluwatomisin Atolagbe has written about Receptors, Immunologic.
Oluwatomisin Atolagbe
Connection Strength
0.179
Receptors, Immunologic
  1. LILRB4 suppresses immunity in solid tumors and is a potential target for immunotherapy. J Exp Med. 2021 07 05; 218(7).
    View in: PubMed
    Score: 0.179
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.